Medicare Enrolled

Dr. Edward Secunda, D.O.

Family Medicine · Jacksonville Beach, FL
Low-engagement
14011 BEACH BLVD, Jacksonville Beach, FL 32250
9042236400
In practice since 2006 (19 years)
NPI: 1053337782 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Secunda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Secunda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Secunda

Dr. Edward Secunda is a family medicine in Jacksonville Beach, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Secunda received a total of $5,043 from 44 pharmaceutical and/or device companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Secunda is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $5,043 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$5,043
Total received (2018-2022)
Avg $1,009/year across 5 years
Top 10% in FL for family medicine
44
Companies
269
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,043 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$15
2021
$449
2020
$1,569
2019
$1,324
2018
$1,686

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$847
GlaxoSmithKline, LLC.
$664
AstraZeneca Pharmaceuticals LP
$531
SANOFI-AVENTIS U.S. LLC
$317
Novartis Pharmaceuticals Corporation
$276
Lilly USA, LLC
$261
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$211
Astellas Pharma US Inc
$204
MERZ NORTH AMERICA, INC.
$179
Amarin Pharma Inc.
$162
Antares Pharma, Inc.
$136
PFIZER INC.
$102
AbbVie Inc.
$89
Genentech USA, Inc.
$88
Janssen Pharmaceuticals, Inc
$76
Daiichi Sankyo Inc.
$72
Avanir Pharmaceuticals, Inc.
$72
Allergan, Inc.
$71
Sunovion Pharmaceuticals Inc.
$69
Insulet Corporation
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Circassia Pharmaceuticals Inc
$41
Allergan Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$37
Teva Pharmaceuticals USA, Inc.
$35
Nalpropion Pharmaceuticals LLC
$30
VIVUS, Inc.
$29
Orexigen Therapeutics, Inc.
$28
Currax Pharmaceuticals LLC
$25
Phadia US Inc.
$25
Flexion Therapeutics, Inc.
$25
Amgen Inc.
$23
JAZZ PHARMACEUTICALS INC.
$22
Otsuka America Pharmaceutical, Inc.
$21
Jazz Pharmaceuticals Inc.
$20
Eisai Inc.
$17
AbbVie, Inc.
$16
Hologic, LLC
$15
Vanda Pharmaceuticals Inc.
$15
Aytu BioScience, Inc
$15
Arbor Pharmaceuticals, Inc.
$14
MannKind Corporation
$11
Merck Sharp & Dohme Corporation
$11
Pernix Therapeutics Holdings, Inc.
$11
Top 3 companies account for 40.5% of total payments
Associated products mentioned in payments ›
ABILIFY MYCITE · AFREZZA · AJOVY · ANORO · ANORO ELLIPTA · Aptima HPV · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · CHANTIX · CONTRAVE · CYCLOSET · DUAKLIR PRESSAIR · Dayvigo · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · HETLIOZ · INJECTAFER · ImmunoCAP · JARDIANCE · LINZESS · MYRBETRIQ · NUEDEXTA · Natesto · ONZETRA Xsail · Omnipod · Otrexup · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · QSYMIA · RELISTOR · RYBELSUS · SOLIQUA · SUNOSI · SYMBICORT · SYNTHROID · Saxenda · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Victoza · XARELTO · XEOMIN · XIFAXAN · XOLAIR · XYOSTED · Xofluza · Xolair · ZOHYDRO ER · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for family medicine in FL.

Looking for a family medicine in Jacksonville Beach?
Compare family medicines in the Jacksonville Beach area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
743
Per 100K population
73.8
County median income
$68,447
Nearest hospital
BAPTIST MEDICAL CENTER BEACHES
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2022
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Secunda is a family medicine, and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Secunda receive payments from pharmaceutical companies?
Yes. Dr. Secunda received a total of $5,043 from 44 companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Secunda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →